Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Combining Lymphoma Molecular Profiles, Microenvironment Signatures May Improve Prognosis

Combining Lymphoma Molecular Profiles, Microenvironment Signatures May Improve Prognosis

Dec 19, 2019
|
Charlotte Hu
Premium

NEW YORK – A research collaboration between biomedical software startup BostonGene and Weill Cornell Medicine has found that the tumor microenvironment influences the prognosis of patients with diffuse large B-cell lymphoma (DLBCL), suggesting that genomics alone may not provide a complete picture of a patient's disease trajectory. 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Not Quite There Yet

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

Call for Open Science

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Accolades for a New University

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

Nucleic Acids Research Papers on IndiGenomes, DockCoV2, ViruSurf Databases

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.

Oct
29
Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov
03
Featured Webinar

A Streamlined Targeted NGS Workflow for Comprehensive Genomic Profiling of Different Tumor Samples

Sponsored by
Agilent

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.

Nov
09
Featured Webinar

The Tumor Neighborhood Watch: How Spatial Architecture and Cellular Neighborhoods Correlate to Colorectal Cancer Outcomes

Sponsored by
Akoya Biosciences

Most recent single-cell and spatial biology studies have focused on the network of interactions between different cell types and their spatial context. 

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Sequencing

  1. Biodesix Prices $72M IPO

  2. Roche, Fabric Genomics Ink Comarketing Agreement for Whole-Exome Sequencing Solution

  3. Ancient Plague Genomes Point to Sources of Outbreaks in Europe After Black Death Pandemic

  4. Illumina's ExpansionHunter Software Shows Clinical Promise for STR Expansions

    Premium

  5. Caris Life Sciences Raises $310M Through Equity, Debt Financing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.